Deals an evolving art

Dealmaking in the life sciences business is accelerating and continues to evolve into new forms. The old pattern of patient, round-by-round investment in startup companies and slow development over years has not disappeared, but now shares the landscape with new ways of buying, selling, developing and financ ing companies, products and technologies. At the same time, new challenges have arisen that will spur further innovation in dealmaking.